Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding FR:EMSR?
Track your performance easily
FR:EMSR Price & Analysis
EMSR ETF Chart & Stats
Day’s Range― - ―
52-Week Range$126.92 - $156.44
Previous Close$146.37
VolumeN/A
Average Volume (3M)498.00
AUM21.62K
NAV147.97
Expense Ratio0.30%
Holdings Count61
Beta0.61
Inception DateJul 21, 2016
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.06
10 Day Avg. Volume47
30 Day Avg. Volume498
Alpha0.00060
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EMSR) Fund Flow Chart
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (EMSR) 1 year Net Flows: -$210M
EMSR ETF News
EMSR ETF FAQ
What was FR:EMSR’s price range in the past 12 months?
FR:EMSR lowest ETF price was $126.92 and its highest was $156.44 in the past 12 months.
What is the AUM of FR:EMSR?
As of Nov 04, 2024 The AUM of FR:EMSR is 21.62K.
Is FR:EMSR overvalued?
According to Wall Street analysts FR:EMSR’s price is currently Undervalued.
Does FR:EMSR pay dividends?
FR:EMSR does not currently pay dividends.
How many shares outstanding does FR:EMSR have?
Currently, no data Available
Which hedge fund is a major shareholder of FR:EMSR?
Currently, no hedge funds are holding shares in FR:EMSR
Top 10 Holdings
U.S. Dollar
11.57%
BNP Paribas SA (UK)
8.83%
AXA SA (UK)
6.53%
Lanxess (OTC)
6.27%
Compagnie de Saint Gobain
5.69%
Credit Agricole SA (UK)
4.96%
Societe Generale (UK)
3.76%
Schneider Electric SE (UK)
3.56%
BNP Paribas InstiCash SICAV - BNP Paribas InstiCash USD 1D LVNAV I Capitalisation
3.50%
Knorr-Bremse AG
3.21%
Total57.87%
ETF Description
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF Capitalisation
The Fund seeks to replicate (with a maximum tracking error of 1%) the performance of the MSCI Emerging SRI S-Series PAB 5% Capped (NTR) index (Bloomberg: M7CXESC index) (the Index) by investing in a substitute basket, composed of, inter alia, shares of companies, debt securities or cash (synthetic replication).